Cargando…
Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes
The challenges of achieving optimal glycemic control in type 2 diabetes highlight the need for new therapies. Inappropriately elevated endogenous glucose production (EGP) is the main source of hyperglycemia in type 2 diabetes. Because activation of central ATP-sensitive potassium (K(ATP)) channels s...
Autores principales: | Esterson, Yonah B., Carey, Michelle, Boucai, Laura, Goyal, Akankasha, Raghavan, Pooja, Zhang, Kehao, Mehta, Deeksha, Feng, Daorong, Wu, Licheng, Kehlenbrink, Sylvia, Koppaka, Sudha, Kishore, Preeti, Hawkins, Meredith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001178/ https://www.ncbi.nlm.nih.gov/pubmed/27207526 http://dx.doi.org/10.2337/db15-1465 |
Ejemplares similares
-
Central K(ATP) Channels Modulate Glucose Effectiveness in Humans and Rodents
por: Carey, Michelle, et al.
Publicado: (2020) -
Reduced Adipose Tissue Macrophage Content Is Associated With Improved Insulin Sensitivity in Thiazolidinedione-Treated Diabetic Humans
por: Koppaka, Sudha, et al.
Publicado: (2013) -
Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice
por: Lontchi-Yimagou, Eric, et al.
Publicado: (2020) -
4261 Insulin Sensitizing Effects of Vitamin D Mediated through Reduced Adipose Tissue Inflammation and Fibrosis: Evidence from a Human Randomized Trial and Mice Studies
por: Yimagou, Eric Lontchi, et al.
Publicado: (2020) -
Opioid Receptor Activation Impairs Hypoglycemic Counterregulation in Humans
por: Carey, Michelle, et al.
Publicado: (2017)